RAP 0.00% 20.5¢ raptor resources limited

2 glaring issues for DX that I believe RAP needs to fix:1) Tony...

  1. 644 Posts.
    lightbulb Created with Sketch. 81
    2 glaring issues for DX that I believe RAP needs to fix:

    1) Tony is still talking about DX as an "ADD-ON":
    DX is only available to Telehealth providers (Coviu and Phenix) as a 3rd party add-on is very disappointing.
    Doctors are not going to download add-ons. I wouldn't want my GP using a 3rd party app to diagnose me either- I personally would not trust it.
    DX needs to be integrated into the platforms and backed by the providers to offer training / education on its use.

    2) Branding:
    The current implementation does not instill confidence for consumers or doctors - If DX was branded as a clinically validated "virtual stethoscope" and integrated into an established platform (Healthdirect or Coviu) I think it would have far better uptake.

    "Virtual stethoscope" works as both consumers and doctors will immediately understand what it's for and what gap it fills in a teleheath setting.
    The Stethoscope has been a trusted clinical tool for almost 200 years and is still used in most respiratory consultations. Who would trust a doctor to diagnose their respiratory condition without using one.

    Feel free to email these suggestions to Tony
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.